Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU)
By: Bhavesh P. Depani, Anuja A. Naik and Hema A. Nair
Open Access
|Dec 2013References
- 1. S. C. Sweetman, Martindale the Complete Drug Reference (Ed. S. C. Sweetman), 34th ed., Pharmaceutical Press, London 2005, pp. 554-556.
- 2. E. Reed, J. Jacob, R. F. Ozols, R. C. Young and C. Allegra, 5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma, Gynecol. Oncol.(1992) 326-329; DOI: 10.1016/0090-8258(92)90226-9.
- 3. www.rxlist.com, accessed on 25th July 2011.
- 4. A. Goodman and L. Gilman, Antineoplastic Agents, in Manual of Pharmacology and Therapeutics (Ed. K. Parker), 11th ed., McGraw Hill, New York 2008, pp. 874-876.
- 5. M. Markman, Intraperitoneal antineoplastic drug delivery: rationale and results, Lancet Oncol.(2003) 277-283; DOI: 10.1016/S1470-2045(03)01074-X.
- 6. A. Chenite, M. Buschmann, D. Wang, C. Chaput and N. Kandani, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym.(2001) 39-47; DOI: 10.1016/S0144-8617(00)00281-2.
- 7. W. Jie, S. Zhi-Guo and M. Guang-Hui, A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate, Int. J. Pharm.(2006) 1-11; DOI: 10.1016/j.ijpharm.2006.01.04.
- 8. Y. Wang, N. Xu, Q. Luo, Y. Li, L. Sun, H. Wang, K. Xu, B. Wang and Y. Zhen, In vivo assessment of chitosan/â-glycerophosphate as a new liquid embolic agent, Interv. Neuroradiol.(2011) 87-92.
- 9. E. Ruel-Gariepy and L. Jean-Christophe, In situ-forming hydrogels-review of temperature-sensitive systems, Eur. J. Pharm. Biopharm.(2004) 409-426; DOI: 10.1016/j.ejpb.2004.03.019.
- 10. E. Ruel-Gariepy, A. Chenite, C. Chaput, S. Guirguis and J. Leroux, Characterization of thermosensitive chitosan gels for the sustained delivery of drugs, Int. J. Pharm.(2000) 89-98; DOI: 10.1016/S0378-5173(00)00428-2.
- 11. OECD guideline 425 for the testing of chemicals. Section 4, Acute Oral Toxicity: Up-and-Down Procedure.
- 12. G. Carlsson, B. Gullberg and L. Hafstrom, Estimation of liver tumor volume using different formulas - an experimental study in rats, J. Cancer Res. Clin. Oncol.(1983) 20-23; DOI: 10.1007/ BF00391826.
- 13. M. M. Tomayko and C. P. Reynolds, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol.(1989) 148-154; DOI: 10.1007/BF00300234.
- 14. B. Jeong, S. W. Kim and Y. H. Bae, Thermosensitive sol-gel reversible hydrogels, Adv. Drug Deliv. Rev.(2002) 37-51; DOI: 10.1016/S0169-409X(01)00242-3.
- 15. F. Ganji, M Abdekhodaie and S. A. Ramazani, Gelation time and degradation rate of chitosan- -based injectable hydrogel, J. Sol-Gel Sci. Tech.(2007) 47-53; DOI: 10.1007/s10971-006-9007-1.
- 16. D. Anderson and D. M. Conning, Experimental Toxicology: the Basic Issues, 2nd ed., Royal Society of Chemistry, California 1993, p. 17.
- 17. A. M. Fan, L. W. Chang, Toxicology and Risk Assessment; Principles, Methods and Application, 4th ed., Marcel Dekker Inc., New York 1996, pp. 108-110.
- 18. J. L. Speyer, P. H. Sugarbaker, J. M. Collins, R. L. Dedrick, R. W. Klecker and C. E. Myers, Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans, Cancer Res.(1981) 1916-1922.
- 19. M. J. Ellenhorn, Ellenhorn’s Medicinal Toxicology; Diagnosis and Treatment of Human Poisoning (Ed. M. J. Ellenhorn), 2nd ed., Williams and Wilkins, Baltimore 1997, p. 1326.
- 20. R. L. Schilsky, K. E. Choi, J. Grayhack, D. Grimmer, C. Guarnieri and L. Fullem, Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intra-abdominal cancer, J. Clin Oncol.(1990) 2054-2061.
- 21. M. Ravi Kumar, R. Muzzarelli and C. Muzzarelli, Chitosan chemistry and pharmaceutical perspectives, Chem. Rev.(2004) 6017-6084; DOI: 10.1002/chin.200511296.
- 22. R. Zange, Y. Li and T. Kissel, Biocompatibility testing of ABA triblock copolymers consisting of poly (L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models, J. Control. Release(1998) 249-258; DOI: 10.1016/S0168-3659(98)00093-5.
- 23. R. Ahmadi, M. Zhou, J. D. De Bruijn, The use of thermo-sensitive chitosan as an injectable carrier for bone tissue engineering, Eur. Cell Mater.(2005) 61.
Language: English
Page range: 479 - 491
Published on: Dec 31, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2013 Bhavesh P. Depani, Anuja A. Naik, Hema A. Nair, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.